The Primary Care Companion for CNS Disorders

CME Institute

Home | About Us | Mission Statement | All CME Activities | MyCME | CME Facebook | CME Twitter

JCP

Home | About JCP | Subscribe | Archive | Information for Authors | Information for Reviewers | Information for Advertisers | CNS Job Market | Customer Service | JCP Facebook | JCP Twitter

PCC

Home | About PCC | Register | Archive | Information for Authors | Information for Reviewers | PCC Facebook | PCC Twitter

Help

FAQ | About Psychiatrist.com | Terms of use | Privacy policy

magnifying glass for search

  • magnifying glass for search
  • Advanced Search

Login

Login  
Login | Login Help | Register | Subscribe
Register | Elerts

Quick Links

Font: A | A | A

Top

Purchase PDF

Vol 14, No 3
Table of Contents

Facebook ShareShare

twitter shareTweet This

envelope iconEmail a link

Related ►

Related Articles

[X]

<p class="frontmatter-fieldnotes disclaimernew" style="margin-bottom:15px;">This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s <a href="/pages/termsofuse.aspx" target="_blank">Terms & Conditions</a>.</p> <div id="x11l01328">
<div class="story">
<p class="ltrs-br-ltr-br-title"><span class="bold">Successful Electroconvulsive Therapy in a Young Woman With Chronic Catatonia</span></p>
<p class="ltrs-br-ltr-br-body-text"><span class="semibold">To the Editor:</span> Catatonia is a motor dysregulation syndrome with multiple etiologies and is associated with a variety of neurologic disorders, general medical conditions, and reactions to medications.<span class="htm-cite"><a href="#ref1">1–3</a></span> Recent studies suggest that catatonia should be conceptualized as an independent syndrome, which facilitates accurate diagnosis and appropriate anticatatonic treatments.<span class="htm-cite"><a href="#ref2">2</a></span> Catatonia typically responds to anticonvulsants, mainly benzodiazepines, and electroconvulsive therapy (ECT).<span class="htm-cite"><a href="#ref2">2</a></span> However, the therapeutic value of benzodiazepines and ECT in chronic catatonia is less well established.<span class="htm-cite"><a href="#ref4">4</a></span> Only 20% to 30% of schizophrenic patients with catatonic symptoms respond to benzodiazepines. Thus, identifying those patients with potentially reversible symptoms is important.</p>
<p class="ltrs-br-ltr-br-body-text">Here, we report the case of a patient with chronic catatonia who presented with a chronic fluctuating course of idiopathic catatonia and responded well to subsequent ECT.</p>
<p class="ltrs-br-ltr-br-body-text">&nbsp;</p>
<p class="ltrs-br-ltr-br-body-text"><span class="semibold-ital">Case report.</span> Ms A, a 25-year-old Dutch woman, was admitted to our clinic due to the uncertainty of the diagnosis and to exclude a somatic origin of symptoms. She was initially diagnosed with <span class="italic">DSM-IV</span> major depressive disorder with psychotic symptoms at age 22 years and over time had been prescribed quetiapine, initially 100 mg/d and subsequently 50 mg/d for 11 days, at which time she was switched to citalopram 20 mg/d and subsequently 10 mg/d for 6 months (<span class="callout"><a target="_blank" onclick="createFigure('t1'); return false;" href="#">Table 1</a></span>). Meanwhile, at another psychiatric hospital, a diagnosis of conversion disorder was suggested, with psychotic disorder as a possible differential diagnosis.</p>
<div id="figure-2">
<a target="_blank" onclick="createFigure('t1'); return false;" href="#"><img border="0" id="t1" alt="Table 1" src="11l01328t1.gif" name="rotate" /></a>
<p class="click-to-enlarge">Click figure to enlarge</p>
</div><img border="0" id="t1r" alt="Table 1r" src="11l01328t1r.gif" style="display:none;"/>
<p class="ltrs-br-ltr-br-body-text">When she was presented to our unit in October 2009, the patient was mute and displayed posturing, rigidity, staring, severe ambitendency, withdrawal, negative thoughts, and frequent grimacing. She ate and drank only modestly, with much support. Furthermore, the pattern of symptoms was extremely fluctuating.</p>
<p class="ltrs-br-ltr-br-body-text">Physical examination revealed cogwheel rigidity of the arms and emerging contractures of the hands, as well as increased reflexes of the arms and legs. Furthermore, there was an occurrence of waxy flexibility as well as acrocyanosis with a slow capillary refill of the toes, interpreted as venous stasis with immobility. A duplex ultrasound examination excluded circulatory stenosis or arterial anomalies and a rheumatoid origin of symptoms. Neurologic and internal examinations excluded a potential somatic origin of the disorder.</p>
<p class="ltrs-br-ltr-br-body-text">A few days after admission, due to the suspected catatonia, treatment with oxazepam 50 mg 4 times daily was commenced. After 4 weeks of clinical observation, the diagnosis of chronic catatonia was established and ECT treatment was started due to an inadequate response to the benzodiazepine treatment. Initially, ECT treatment was bilateral, twice a week (Thymatron System IV, Somatics, LLC, Lake Bluff, Illinois; bilateral, impulse width 0.5 msec, energy set first 53 treatments 5% to 100% and second 15 treatments 5% to 35%, adequate seizure duration<span class="thinspace"> </span>&gt;<span class="thinspace"> </span>20 sec EMG).</p>
<p class="ltrs-br-ltr-br-body-text">The patient showed slow, but gradual, improvements in speech, motoric function, mime, and social contact. The frequency of ECT treatments was therefore increased to 3 times a week, producing further improvements. Because ECT induced severe difficulty with information encoding, the frequency of ECT was, after 25 bilateral ECT treatment sessions, reduced to twice a week. The patient responded with a deterioration of symptoms such as less communication and increased muscle tension. Therefore, after 3 weeks the frequency of ECT was reinstated to 3 times a week, resulting in symptom improvement. Clinical symptoms improved significantly with ECT, and activities of daily routine improved steadily. However, when ECT was fully stopped in June 2010, symptoms deteriorated again, with the patient showing less communication, increased muscle tension, increased ambitendency, and decreased initiative. Meanwhile, a psychotic disorder with catatonia or catatonic schizophrenia was considered, and ECT was restarted twice a week along with the addition of olanzapine (up to 10 mg/d). With this treatment, she was able to speak in whole sentences, started to walk spontaneously, and showed more initiative and less ambitendency.</p>
<p class="ltrs-br-ltr-br-body-text">In August 2010, the clinical symptoms improved gradually and she was discharged with a prescription of olanzapine 10 mg/d and ECT twice a week. Between January and June 2011, the patient was further followed at the outpatient clinic of a regional hospital.</p>
<p class="ltrs-br-ltr-br-body-text">&nbsp;</p>
<p class="ltrs-br-ltr-br-body-text">To the best of our knowledge, this unique case showed that, despite an insidious onset and an atypical, fluctuating course of catatonic symptoms, the diagnosis of catatonia should be considered and, as in acute catatonia, ECT can be effective in chronic catatonia. Studies of more patients with similar presentation are needed to develop an empirically based treatment approach.</p>
<p class="ltrs-br-ltr-br-references-head"><span class="smallcaps">References</span></p>
<p class="references-references-text-1-9"><a name="ref1"></a>1. Fink M. Delirious mania. <span class="italic">Bipolar Disord</span>. 1999;1(1):54–60. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11256658&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.1034/j.1399-5618.1999.10112.x">doi:10.1034/j.1399-5618.1999.10112.x</a></span></p>
<p class="references-references-text-1-9"><a name="ref2"></a>2. Fink M, Taylor MA. <span class="italic">Catatonia: A Clinician’s Guide to Diagnosis and Treatment</span>. Cambridge, UK: Cambridge University Press; 2003. <span class="pubmed-crossref"><a href="http://dx.doi.org/10.1017/CBO9780511543777">doi:10.1017/CBO9780511543777</a></span></p>
<p class="references-references-text-1-9"><a name="ref3"></a>3. Fink M, Taylor MA. The catatonia syndrome: forgotten but not gone. <span class="italic">Arch Gen Psychiatry</span>. 2009;66(11):1173–1177. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19884605&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.1001/archgenpsychiatry.2009.141">doi:10.1001/archgenpsychiatry.2009.141</a></span></p>
<p class="references-references-text-1-9"><a name="ref4"></a>4. Gibson RC, Walcott G. Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses. <span class="italic">Cochrane Database Syst Rev</span>. 2008;8(4):CD006570. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18843722&dopt=Abstract">PubMed</a></span></p>
<p class="ltrs-br-ltr-br-author" style="margin-top:15px;"><span class="bold">Heval Ozgen, MD, PhD</span></p>
<p class="ltrs-br-ltr-br-author"><a href="mailto:h.ozgen@umcutrecht.nl">h.ozgen@umcutrecht.nl</a></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Jaap Wijkstra, MD, PhD</span></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Jacob Vorstman, MD, PhD</span></p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Author affiliations:</span> Department of Psychiatry and Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, The Netherlands.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Potential conflicts of interest:</span> None reported.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Funding/support: </span>None reported.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Published online:</span> June 21, 2012.</p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">Prim Care Companion CNS Disord 2012;14(3):</span><span class="doi">doi:10.4088/PCC.11l01328</span></p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">© Copyright 2012 Physicians Postgraduate Press, Inc.</span></p>
</div>
</div>
Manage Subscriptions
/_layouts/images/ReportServer/Manage_Subscription.gif
/PCC/article/_layouts/ReportServer/ManageSubscriptions.aspx?list={ListId}&ID={ItemId}
0x80
0x0
FileType
rdl
350
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rdl
351
Manage Shared Datasets
/PCC/article/_layouts/ReportServer/DatasetList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rdl
352
Manage Parameters
/PCC/article/_layouts/ReportServer/ParameterList.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
353
Manage Processing Options
/PCC/article/_layouts/ReportServer/ReportExecution.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
354
Manage Cache Refresh Plans
/PCC/article/_layouts/ReportServer/CacheRefreshPlanList.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
355
View Report History
/PCC/article/_layouts/ReportServer/ReportHistory.aspx?list={ListId}&ID={ItemId}
0x0
0x40
FileType
rdl
356
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsds
350
Edit Data Source Definition
/PCC/article/_layouts/ReportServer/SharedDataSource.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsds
351
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
350
Manage Clickthrough Reports
/PCC/article/_layouts/ReportServer/ModelClickThrough.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
352
Manage Model Item Security
/PCC/article/_layouts/ReportServer/ModelItemSecurity.aspx?list={ListId}&ID={ItemId}
0x0
0x2000000
FileType
smdl
353
Regenerate Model
/PCC/article/_layouts/ReportServer/GenerateModel.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
354
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
smdl
351
Load in Report Builder
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderModelContext&list={ListId}&ID={ItemId}
0x0
0x2
FileType
smdl
250
Edit in Report Builder
/_layouts/images/ReportServer/EditReport.gif
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderReportContext&list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
250
Edit in Report Builder
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderDatasetContext&list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
250
Manage Caching Options
/PCC/article/_layouts/ReportServer/DatasetCachingOptions.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
350
Manage Cache Refresh Plans
/PCC/article/_layouts/ReportServer/CacheRefreshPlanList.aspx?list={ListId}&ID={ItemId}&IsDataset=true
0x0
0x4
FileType
rsd
351
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rsd
352
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
353
Compliance Details
javascript:commonShowModalDialog('{SiteUrl}/_layouts/itemexpiration.aspx?ID={ItemId}&List={ListId}', 'center:1;dialogHeight:500px;dialogWidth:500px;resizable:yes;status:no;location:no;menubar:no;help:no', function GotoPageAfterClose(pageid){if(pageid == 'hold') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/hold.aspx?ID={ItemId}&List={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/Reporting.aspx?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/expirationconfig.aspx?ID={ItemId}&List={ListId}'); return false;}}, null); return false;
0x0
0x1
ContentType
0x01
898
Document Set Version History
javascript:SP.UI.ModalDialog.ShowPopupDialog('{SiteUrl}/_layouts/DocSetVersions.aspx?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
330
Send To other location
javascript:GoToPage('{SiteUrl}/_layouts/docsetsend.aspx?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
350

Information Links

Terms of Use | Privacy Policy | Information for Authors (JCP) | Information for Authors (PCC) | Reprints and Permissions | CNS Job Market | Information for Advertisers | Media Relations | PPP COVID-19 Statement

Help

Contact us | Unsubscribe from Elerts | Customer Service | FAQ | About JCP | About PCC | About Psychiatrist.com

Our Family of Sites

Psychiatrist.com | The Journal of Clinical Psychiatry | The Primary Care Companion | The CME Institute | Strong Veterans
Anonymous